Literature DB >> 7409031

A method for quantification of peripheral blood admixture in bone marrow aspirates.

R S Holdrinet, J von Egmond, J M Wessels, C Haanen.   

Abstract

Peripheral blood admixture in bone marrow aspirates of twenty patients with hematologic diseases were studied either with 51Cr labeled autologous erythrocytes or 125I-lab eled albumin. In these bone marrow aspirates 97.0 +/- 4.2% (mean +/- SD) of te hemoglobin content appeared to be derived from peripheral blood. Assuming the presence of a proportional number of peripheral nucleated cells one may calculate the fraction of peripheral nucleated cells in bone marrow aspirates (Fpb) from its hemoglobin levels. The Fpb in the twenty patients studied, varied from 6 to 93%, whereas in a group of 25 healthy volunteers the mean Fpb +/- SD was 14 +/- 8%. In order to obtain reliable results in quantitative bone marrow studies one has to take into account the fraction of peripheral nucleated cells in bone marrow aspirates.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7409031

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

1.  Cell cycle kinetics of hematopoiesis before and after in vivo administration of GM-CSF in refractory anemia: evidence for a shortening of the granulocyte release time.

Authors:  P P Brons; N Van der Lely; C Haanen; A H Pennings; J B Boezeman; J M Wessels; R A Raijmakers; T J de Witte
Journal:  Ann Hematol       Date:  1994-04       Impact factor: 3.673

2.  Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors:  Valérie Bardet; Orianne Wagner-Ballon; Julien Guy; Céline Morvan; Camille Debord; Franck Trimoreau; Emmanuel Benayoun; Nicolas Chapuis; Nicolas Freynet; Cédric Rossi; Stéphanie Mathis; Marie-Pierre Gourin; Andréa Toma; Marie C Béné; Jean Feuillard; Estelle Guérin
Journal:  Haematologica       Date:  2015-01-30       Impact factor: 9.941

3.  Techniques for obtaining differential cell counts from bone marrow trephine biopsy specimens.

Authors:  B S Wilkins; C J O'Brien
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

4.  Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.

Authors:  Anna M Aalbers; Marry M van den Heuvel-Eibrink; Irith Baumann; Michael Dworzak; Henrik Hasle; Franco Locatelli; Barbara De Moerloose; Markus Schmugge; Ester Mejstrikova; Michaela Nováková; Marco Zecca; C Michel Zwaan; Jeroen G Te Marvelde; Anton W Langerak; Jacques J M van Dongen; Rob Pieters; Charlotte M Niemeyer; Vincent H J van der Velden
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

5.  A Novel Method to Assess Bone Marrow Purity is Useful in Determining Blast Percentage by Flow Cytometry in Acute Myeloid Leukemia and Myelodysplasia.

Authors:  A M Aldawood; Z Kinkade; F G Rosado; O A Esan; L F Gibson; J A Vos
Journal:  Ann Hematol Oncol       Date:  2015

6.  Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients.

Authors:  P A Speth; P C Linssen; J B Boezeman; H M Wessels; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Effects of prolonged processing in standard and isotonic trichloroacetic acid (TCA) on cellular preservation in bone marrow trephines.

Authors:  R J Fitzmaurice; A Pitalia; A J Freemont
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

8.  Cell kinetics after high dose cytosine arabinoside in patients with acute myelocytic leukemia.

Authors:  L P Colly; W G Peters; M W Arentsen-Honders; R Willemze
Journal:  Blut       Date:  1990-02

9.  T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.

Authors:  William Vernau; Brian J Hartnett; Douglas R Kennedy; Peter F Moore; Paula S Henthorn; Kenneth I Weinberg; Peter J Felsburg
Journal:  Biol Blood Marrow Transplant       Date:  2007-08-02       Impact factor: 5.742

10.  Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.

Authors:  P A Speth; P C Linssen; J B Boezeman; H M Wessels; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.